Corlanor is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Ivabradine Hydrochloride.
Product ID | 55513-810_17727cc4-117c-47b3-bf1d-bbc2968c51b6 |
NDC | 55513-810 |
Product Type | Human Prescription Drug |
Proprietary Name | Corlanor |
Generic Name | Ivabradine |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2015-04-20 |
Marketing Category | NDA / NDA |
Application Number | NDA206143 |
Labeler Name | Amgen Inc |
Substance Name | IVABRADINE HYDROCHLORIDE |
Active Ingredient Strength | 8 mg/1 |
Pharm Classes | Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC],Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-04-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206143 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-04-20 |
Marketing Category | NDA |
Application Number | NDA206143 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-04-20 |
Ingredient | Strength |
---|---|
IVABRADINE HYDROCHLORIDE | 7.5 mg/1 |
SPL SET ID: | 92018a65-38f6-45f7-91d4-a34921b81d0d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
55513-800 | Corlanor | ivabradine |
55513-810 | Corlanor | ivabradine |
55513-813 | Corlanor | ivabradine |
70518-3309 | Corlanor | ivabradine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CORLANOR 79157808 4834147 Live/Registered |
BIOFARMA 2014-10-03 |
CORLANOR 77684533 3751418 Live/Registered |
BIOFARMA 2009-03-05 |